✦ LIBER ✦

Clinical, Pathologic, and Immunohistochemical Characteristics of Gastrointestinal Stromal Tumors of the Colon and Rectum: Implications for Surgical Management and Adjuvant Therapies

✍ Scribed by Imran Hassan; Y. Nancy You; Eric J. Dozois; Roman Shayyan; Thomas C. Smyrk; Scott H. Okuno; John H. Donohue

Publisher: Springer
Year: 2006
Tongue: English
Weight: 163 KB
Volume: 49
Category: Article
ISSN: 0012-3706
DOI: 10.1007/s10350-006-0503-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adjuvant and neoadjuvant imatinib therap

Adjuvant and neoadjuvant imatinib therapy: Current role in the management of gastrointestinal stromal tumors

✍ Burton L. Eisenberg; Jonathan C. Trent 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 212 KB

## Abstract Although surgery remains the mainstay for the treatment of primary gastrointestinal stromal tumors (GIST), a significant number of patients experience disease recurrence within 5 years of surgery. The emergence of imatinib therapy for the treatment of patients with advanced GIST has off

Risk of cerebral metastases and neurolog

Risk of cerebral metastases and neurological death after pathological complete response to neoadjuvant therapy for locally advanced nonsmall-cell lung cancer : Clinical implications for the subsequent management of the brain

✍ Allen M. Chen; Thierry M. Jahan; David M. Jablons; Joaquin Garcia; David A. Lars 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB

## Abstract ## BACKGROUND. The incidence and pattern of brain metastases was analyzed among patients who achieved a pathological complete response (pCR) after neoadjuvant chemotherapy or chemoradiotherapy for locally advanced nonsmall‐cell lung cancer (NSCLC). ## METHODS. Between 1990 and 2004,